{
    "nctId": "NCT02701244",
    "briefTitle": "A Registry Study of Breast Microseed Treatment",
    "officialTitle": "A Multicenter Registry Study of Breast Microseed Treatment for Early Stage Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 420,
    "primaryOutcomeMeasure": "Serious Adverse Events (SAE)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histological diagnosis of invasive or in-situ ductal carcinoma (DCIS)\n* Treated by breast conserving surgery with axillary node dissection (with a minimum of 6 nodes sampled) or sentinel lymph node biopsy\n* Surgical margins clear for invasive carcinoma (no tumor at ink margin) or superior or equal to 2 mm for in-situ ductal carcinoma (DCIS)\n* A maximum tumor size of 3 cm\n* Age \u226550 years old\n* Informed consent signed if participating in the Registry\n\nExclusion Criteria:\n\n* No previous cancer unless in remission for more than 2 years.\n* Active auto immune disorder with severe vasculitis component\n* Uncontrolled and complicated insulin-dependent diabetes\n* Pregnancy\n* Cosmetic breast implants\n* Psychiatric or addictive disorder that would preclude attending follow-up\n* Post-operative breast infection requiring prolonged antibiotic therapy\n* Lobular features on histology (pure or mixed) or sarcoma histology\n* Node macroscopically positive on axillary dissection or in the sentinel lymph node biopsy\n* Extensive in- situ carcinoma\n* Multicentric disease (in more than one quadrant or separated by 2 cm or more)\n* Paget's disease of the nipple\n* Metastases\n* Patients presenting with a large post-surgical fluid cavity as determined on the planning Ultrasound (US), resistant to the application of hot compresses for 4 weeks\n* Clear delineation of the target volume on Computerized Tomography (CT) is not possible\n* Volume to be implanted over 150cc\n* Target volume too close to skin such that the 90% isodose overlaps the skin surface",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}